Gastrin regulates growth of human pancreatic cancer in a tonic and autocrine fashion

Jill Palmer Smith, Alan Shih, Yan Wu, Patricia McLaughlin, Ian Zagon

Research output: Contribution to journalArticle

54 Citations (Scopus)

Abstract

The gastrointestinal peptides gastrin and cholecystokinin (CCK) stimulate growth of human pancreatic cancer through a CCK-B/gastrin-like receptor. In the present study we evaluated whether growth of human pancreatic cancer is endogenously regulated by gastrin. Immunohistochemical examination of BxPC-3 cells and tumor xenografts revealed specific gastrin immunoreactivity. Gastrin was detected by radioimmunoassay in pancreatic cancer cell extracts and in the growth media. With use of reverse-transcriptase polymerase chain reaction gastrin gene expression was detected in both cultured BxPC-3 cancer cells and transplanted tumors, as well as seven additional human pancreatic cancer cell lines. Growth of BxPC-3 human pancreatic cancer cells in serum- free medium was inhibited by the addition of the CCK-B/gastrin receptor antagonist L-365,260, and gastrin treatment reversed the inhibitory effect of the antagonist. A selective gastrin antibody (Ab 2604) also repressed growth of BxPC-3 cells. Gastrin immunoreactivity was detected in fresh human pancreatic cancer specimens but not in normal human pancreatic tissue. These data provide the first evidence that growth of a human pancreatic cancer is tonically stimulated by the autocrine production of gastrin. Evidence for the ubiquity of this system was provided by the detection of gastrin gene expression in multiple human pancreatic cancer cell lines and detection of gastrin in cell lines and fresh pancreatic tumors.

Original languageEnglish (US)
JournalAmerican Journal of Physiology - Regulatory Integrative and Comparative Physiology
Volume270
Issue number5 39-5
StatePublished - Jun 25 1996

Fingerprint

Gastrins
Pancreatic Neoplasms
Growth
Cholecystokinin B Receptor
Cholecystokinin
Cell Line
Neoplasms
Gene Expression
Gastrin-Secreting Cells
Serum-Free Culture Media
Cell Extracts
Reverse Transcriptase Polymerase Chain Reaction
Heterografts
Radioimmunoassay
Peptides
Antibodies

All Science Journal Classification (ASJC) codes

  • Physiology
  • Physiology (medical)

Cite this

@article{122fcf51656744498e0866730b90bf13,
title = "Gastrin regulates growth of human pancreatic cancer in a tonic and autocrine fashion",
abstract = "The gastrointestinal peptides gastrin and cholecystokinin (CCK) stimulate growth of human pancreatic cancer through a CCK-B/gastrin-like receptor. In the present study we evaluated whether growth of human pancreatic cancer is endogenously regulated by gastrin. Immunohistochemical examination of BxPC-3 cells and tumor xenografts revealed specific gastrin immunoreactivity. Gastrin was detected by radioimmunoassay in pancreatic cancer cell extracts and in the growth media. With use of reverse-transcriptase polymerase chain reaction gastrin gene expression was detected in both cultured BxPC-3 cancer cells and transplanted tumors, as well as seven additional human pancreatic cancer cell lines. Growth of BxPC-3 human pancreatic cancer cells in serum- free medium was inhibited by the addition of the CCK-B/gastrin receptor antagonist L-365,260, and gastrin treatment reversed the inhibitory effect of the antagonist. A selective gastrin antibody (Ab 2604) also repressed growth of BxPC-3 cells. Gastrin immunoreactivity was detected in fresh human pancreatic cancer specimens but not in normal human pancreatic tissue. These data provide the first evidence that growth of a human pancreatic cancer is tonically stimulated by the autocrine production of gastrin. Evidence for the ubiquity of this system was provided by the detection of gastrin gene expression in multiple human pancreatic cancer cell lines and detection of gastrin in cell lines and fresh pancreatic tumors.",
author = "Smith, {Jill Palmer} and Alan Shih and Yan Wu and Patricia McLaughlin and Ian Zagon",
year = "1996",
month = "6",
day = "25",
language = "English (US)",
volume = "270",
journal = "American Journal of Physiology",
issn = "0363-6119",
publisher = "American Physiological Society",
number = "5 39-5",

}

Gastrin regulates growth of human pancreatic cancer in a tonic and autocrine fashion. / Smith, Jill Palmer; Shih, Alan; Wu, Yan; McLaughlin, Patricia; Zagon, Ian.

In: American Journal of Physiology - Regulatory Integrative and Comparative Physiology, Vol. 270, No. 5 39-5, 25.06.1996.

Research output: Contribution to journalArticle

TY - JOUR

T1 - Gastrin regulates growth of human pancreatic cancer in a tonic and autocrine fashion

AU - Smith, Jill Palmer

AU - Shih, Alan

AU - Wu, Yan

AU - McLaughlin, Patricia

AU - Zagon, Ian

PY - 1996/6/25

Y1 - 1996/6/25

N2 - The gastrointestinal peptides gastrin and cholecystokinin (CCK) stimulate growth of human pancreatic cancer through a CCK-B/gastrin-like receptor. In the present study we evaluated whether growth of human pancreatic cancer is endogenously regulated by gastrin. Immunohistochemical examination of BxPC-3 cells and tumor xenografts revealed specific gastrin immunoreactivity. Gastrin was detected by radioimmunoassay in pancreatic cancer cell extracts and in the growth media. With use of reverse-transcriptase polymerase chain reaction gastrin gene expression was detected in both cultured BxPC-3 cancer cells and transplanted tumors, as well as seven additional human pancreatic cancer cell lines. Growth of BxPC-3 human pancreatic cancer cells in serum- free medium was inhibited by the addition of the CCK-B/gastrin receptor antagonist L-365,260, and gastrin treatment reversed the inhibitory effect of the antagonist. A selective gastrin antibody (Ab 2604) also repressed growth of BxPC-3 cells. Gastrin immunoreactivity was detected in fresh human pancreatic cancer specimens but not in normal human pancreatic tissue. These data provide the first evidence that growth of a human pancreatic cancer is tonically stimulated by the autocrine production of gastrin. Evidence for the ubiquity of this system was provided by the detection of gastrin gene expression in multiple human pancreatic cancer cell lines and detection of gastrin in cell lines and fresh pancreatic tumors.

AB - The gastrointestinal peptides gastrin and cholecystokinin (CCK) stimulate growth of human pancreatic cancer through a CCK-B/gastrin-like receptor. In the present study we evaluated whether growth of human pancreatic cancer is endogenously regulated by gastrin. Immunohistochemical examination of BxPC-3 cells and tumor xenografts revealed specific gastrin immunoreactivity. Gastrin was detected by radioimmunoassay in pancreatic cancer cell extracts and in the growth media. With use of reverse-transcriptase polymerase chain reaction gastrin gene expression was detected in both cultured BxPC-3 cancer cells and transplanted tumors, as well as seven additional human pancreatic cancer cell lines. Growth of BxPC-3 human pancreatic cancer cells in serum- free medium was inhibited by the addition of the CCK-B/gastrin receptor antagonist L-365,260, and gastrin treatment reversed the inhibitory effect of the antagonist. A selective gastrin antibody (Ab 2604) also repressed growth of BxPC-3 cells. Gastrin immunoreactivity was detected in fresh human pancreatic cancer specimens but not in normal human pancreatic tissue. These data provide the first evidence that growth of a human pancreatic cancer is tonically stimulated by the autocrine production of gastrin. Evidence for the ubiquity of this system was provided by the detection of gastrin gene expression in multiple human pancreatic cancer cell lines and detection of gastrin in cell lines and fresh pancreatic tumors.

UR - http://www.scopus.com/inward/record.url?scp=0030011497&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0030011497&partnerID=8YFLogxK

M3 - Article

C2 - 8928909

AN - SCOPUS:0030011497

VL - 270

JO - American Journal of Physiology

JF - American Journal of Physiology

SN - 0363-6119

IS - 5 39-5

ER -